Other or ill-defined heart diseases

I9_OTHILLHEART

heart disease: A disease involving the heart and/or pericardium.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I51, I52* Hospital discharge: ICD-9 — 429 Hospital discharge: ICD-8 — 42899\|42999 Cause of death: ICD-10 — I51, I52* Cause of death: ICD-9 — 429 Cause of death: ICD-8 — 42899\|42999 2 out of 7 registries used, show all original rules.	2260
4. Check minimum number of events None	2260
5. Include endpoints None	2260
6. Filter based on genotype QC (FinnGen only)	2260

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_OTHILLHEART
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I5[1-2]
HD_ICD_9	429
HD_ICD_8	42899\|42999
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I5[1-2]
COD_ICD_9	429
COD_ICD_8	42899\|42999
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other or ill-defined heart diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	33677	12205	20779
Only index persons	17579	6000	11579
Unadjusted period prevalence (%)
Whole population	0.50	0.35	0.58
Only index persons	0.37	0.22	0.44
Median age at first event (years)
Whole population	58.86	65.01	55.08
Only index persons	51.92	58.39	48.57

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2260	826	1434
Unadjusted period prevalence (%)	0.50	0.28	0.63
Median age at first event (years)	55.06	54.70	55.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1999: Matched controls
19996

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I48

ICD-10 Finland

Atrial fibrillation and flutter

90.9

323.0

479

I50.9

ICD-10 Finland

Heart failure, unspecified

84.9

323.0

402

I51.7

ICD-10 Finland

Cardiomegaly

4755.8

323.0

397

I51.4

ICD-10 Finland

Myocarditis, unspecified

6048.1

323.0

787

207

Kela drug reimbursment

Chronic arrhythmias

130.2

273.7

290

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.9

264.0

636

999

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

9.3

260.5

606

895

B01AA03

ATC

warfarin; systemic

9.3

241.0

555

794

I50.0

ICD-10 Finland

Congestive heart failure

218.3

227.6

232

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

6.4

210.4

650

1404

C07AB07

ATC

bisoprolol; oral

4.5

207.9

1067

4038

I50.1

ICD-10 Finland

Left ventricular failure

1077.3

202.7

195

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

249.2

199.5

202

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

176.3

198.8

206

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

186.4

176

C03CA01

ATC

furosemide; systemic

4.9

179.2

726

2088

201

Kela drug reimbursment

Chronic cardiac insufficiency

20.3

162.1

249

139

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

285.8

156.8

158

I51.9

ICD-10 Finland

Heart disease, unspecified

+∞

154.1

146

C01AA05

ATC

digoxin; systemic

15.3

142.6

244

180

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

+∞

137.0

130

TFP20

NOMESCO Finland

Cardiodefibrillation

113.2

136.0

147

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

134.9

128

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

1296.4

126.5

122

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

252.7

117.1

119

C03DA01

ATC

spironolactone; oral

7.0

113.8

304

501

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

125.2

110.3

118

AN1

Coronary angiography

6.0

108.9

330

641

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

106.8

908

4374

XF404

NOMESCO Finland

Ambulatory ECG

9.8

104.9

222

251

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

1050.0

103.1

100

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.4

99.7

405

1080

42999

ICD-8 Finland

Ill-defined heart disease, Other and unspecified heart disease

+∞

97.7

I51.1

ICD-10 Finland

Rupture of chordae tendineae, not elsewhere classified

+∞

94.5

C01BD01

ATC

amiodarone; systemic

115.6

91.8

R07.4

ICD-10 Finland

Chest pain, unspecified

3.1

89.5

619

2526

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

83.9

I47.2

ICD-10 Finland

Ventricular tachycardia

413.4

80.5

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

48.4

79.8

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

798.3

78.9

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

82.7

77.7

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

263.1

74.9

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

199.9

74.7

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

94.9

74.5

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

8.5

73.7

168

213

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

6.5

73.7

203

341

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.1

72.7

484

1883

K78

ICPC

Atrial fibrillation/flutter

15.7

71.4

119

I49.3

ICD-10 Finland

Ventricular premature depolarization

15.7

69.6

116

I44.2

ICD-10 Finland

Atrioventricular block, complete

+∞

69.1

I49.5

ICD-10 Finland

Sick sinus syndrome

658.6

65.3

C09AA05

ATC

ramipril; oral

2.7

62.6

516

2271

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

6.0

62.4

183

332

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

61.8

396

1480

R06.0

ICD-10 Finland

Dyspnoea

2.7

60.8

485

2087

I35.0

ICD-10 Finland

Aortic (valve) stenosis

32.8

60.0

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

60.3

59.9

B01AF02

ATC

apixaban; oral

8.8

58.8

130

156

TFP34

NOMESCO Finland

Electrophysiological investigation

289.2

55.5

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

55.5

XF402

NOMESCO Finland

ECG with work load test

3.9

52.6

236

665

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

499.5

49.6

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

49.1

42899

ICD-8 Finland

Other myocardial insufficiency

+∞

47.0

4298A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[ASTHENIA VASOREGULATORIA]

+∞

47.0

GD1LA

NOMESCO Finland

88.9

47.0

I47.1

ICD-10 Finland

Supraventricular tachycardia

34.3

46.2

Angiography of the heart and coronary arteries

4.6

45.1

166

387

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

6.1

44.4

126

218

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

83.7

44.0

WX892

NOMESCO Finland

Monitored bed care

4.3

43.5

173

435

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

43.2

516

2683

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.4

42.8

427

2030

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

4.7

42.8

153

346

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.5

42.0

382

1729

I51.0

ICD-10 Finland

Cardiac septal defect, acquired

+∞

41.8

I34.1

ICD-10 Finland

Mitral (valve) prolapse

43.5

41.4

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

+∞

40.7

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

40.7

C07AB02

ATC

metoprolol; systemic

2.4

40.3

396

1862

C07AA07

ATC

sotalol; systemic

9.2

39.9

4294A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Functional disturbances following cardiac surgery

+∞

39.7

TFJ02

NOMESCO Finland

Muscle biopsy of heart

+∞

39.7

I51.5

ICD-10 Finland

Myocardial degeneration

+∞

39.7

C01DA14

ATC

isosorbide mononitrate; oral

2.7

39.5

308

1275

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

394.7

39.2

C01BC04

ATC

flecainide; systemic

104.5

37.8

I25.2

ICD-10 Finland

Old myocardial infarction

3.9

37.8

163

441

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

+∞

37.6

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

37.6

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

7.4

37.0

126

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

193.4

36.9

I50

ICD-10 Finland

Heart failure

19.2

36.7

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

36.6

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

35.5

TK800

NOMESCO Finland

Hemodialysis

9.5

35.1

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.2

34.4

137

344

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.6

33.9

161

472

L04AA06

ATC

mycophenolic acid; systemic

9.3

33.2

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

33.0

383

1932

A12BA01

ATC

potassium chloride; oral

4.7

32.7

116

260

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

32.4

I44.1

ICD-10 Finland

Atrioventricular block, second degree

+∞

32.4

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

32.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

32.4

263

1107

H02AB06

ATC

prednisolone; systemic

1.8

32.0

820

5581

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

31.8

310

1438

A02BC02

ATC

pantoprazole; systemic

1.7

30.7

1097

8242

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.9

30.3

C09DX04

ATC

valsartan and sacubitril; oral

+∞

30.3

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

30.3

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

10.3

30.2

XFE00

NOMESCO Finland

Epicardial ultrasonography

9.9

30.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

7.6

30.0

WX872

NOMESCO Finland

Intensive care

4.6

29.6

107

245

127

Kela drug reimbursment

Transplant complication

9.1

28.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

28.6

210

832

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

28.4

271

1238

I48.2

ICD-10 Finland

Chronic atrial fibrillation

+∞

28.2

B33.2

ICD-10 Finland

Viral carditis

+∞

28.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.9

28.1

119

316

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.1

27.9

380

2041

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.8

27.8

188

708

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

78.7

27.8

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

43.1

27.8

I20.09

ICD-10 Finland

Unstable angina

3.8

27.5

121

333

AS4

Physiological pacemaker insertion DDD (R)

+∞

27.1

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

10.1

27.0

ZX120

NOMESCO Finland

Intravenous

2.7

26.7

189

732

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

98.0

26.7

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

26.1

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

26.1

AP1

Catheterization of the left side of the heart

10.4

26.0

I48.1

ICD-10 Finland

Persistent atrial fibrillation

73.6

25.8

C08DA01

ATC

verapamil; systemic

5.6

25.6

140

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

6.9

25.4

AA1AD

NOMESCO Finland

CT of head and brain

2.0

25.4

397

2241

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

14.1

25.4

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

17.0

25.3

R50.9

ICD-10 Finland

Fever, unspecified

2.2

25.0

268

1290

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

9.3

25.0

R07.3

ICD-10 Finland

Other chest pain

2.7

24.8

178

695

1CX08

NOMESCO Finland

253.0

24.7

TFP35

NOMESCO Finland

Electroanatomical mapping

253.0

24.7

Z94.1

ICD-10 Finland

Heart transplant status

131.6

24.6

N05CF01

ATC

zopiclone; oral

1.8

24.0

565

3660

4298X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[MORBUS CORDIS ALIA DEFINITA]

+∞

24.0

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

24.0

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

24.0

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

24.0

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

6.1

24.0

111

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

68.2

23.8

XF640

NOMESCO Finland

7.3

23.6

M04AA01

ATC

allopurinol; systemic

2.3

23.1

230

1070

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

22.3

23.0

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

22.9

R4110

NOMESCO Finland

Physiotherapy

1.8

22.9

450

2743

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.0

22.9

137

476

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

232.4

22.7

L04AX01

ATC

azathioprine; systemic

3.6

22.6

106

308

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

4.6

22.5

181

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

22.0

147

549

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

21.9

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

21.9

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

21.9

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

6.4

21.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

21.6

162

647

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

222.2

21.6

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

5.0

21.5

144

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.4

21.4

186

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

50.5

21.1

B01AB05

ATC

enoxaparin; parenteral

1.8

21.1

465

2936

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

+∞

20.9

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

9.3

20.8

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

5.2

20.5

126

5253

FHL

Cardiac lung machine

10.7

20.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

3.4

20.2

101

309

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

19.9

294

1613

AQ1

Conventional electrophysiological examination

+∞

19.8

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

19.8

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.8

19.8

133

499

FL1AC

NOMESCO Finland

Left cardioangiography

7.4

19.8

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

74.2

19.7

R02

ICPC

Shortness of breath/dyspnoea

2.4

19.6

179

797

K80

ICPC

Cardiac arrhythmia NOS

3.5

19.1

274

K84

ICPC

Heart disease other

6.6

19.0

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.2

19.0

179

A11CC03

ATC

alfacalcidol; systemic

5.5

18.8

105

Z94.0

ICD-10 Finland

Kidney transplant status

8.3

18.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

18.7

173

775

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.1

18.6

183

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

18.4

481

3175

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

18.3

175

795

N05BA04

ATC

oxazepam; oral

1.7

18.2

400

2506

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.3

18.1

286

R03AC02

ATC

salbutamol; inhalant

1.5

18.1

842

6427

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.4

17.9

272

L04AD01

ATC

ciclosporin; systemic

5.3

17.7

104

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

17.7

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

17.5

283

1603

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

10.1

17.4

B01AC04

ATC

clopidogrel; oral

2.0

17.4

243

1303

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

17.3

679

4966

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

17.0

335

2024

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

31.7

17.0

K77

ICPC

Heart failure

11.6

17.0

K83

ICPC

Heart valve disease NOS

50.4

17.0

H02AB04

ATC

methylprednisolone; systemic

2.0

17.0

248

1352

I44.0

ICD-10 Finland

Atrioventricular block, first degree

22.0

16.9

N05BA01

ATC

diazepam; systemic, rectal

2.0

16.8

239

1290

XF409

NOMESCO Finland

Other special ECG

+∞

16.7

I51.6

ICD-10 Finland

Cardiovascular disease, unspecified

+∞

16.7

4293A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Cardiomegaly

+∞

16.7

I40.0

ICD-10 Finland

Infective myocarditis

+∞

16.7

I40.8

ICD-10 Finland

Other acute myocarditis

+∞

16.7

C09AA02

ATC

enalapril; systemic

1.8

16.6

331

2007

AP4

Myocardial biopsy

90.8

16.6

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.8

16.5

188

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

27.8

16.5

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.6

16.4

Z49.1

ICD-10 Finland

Extracorporeal dialysis

9.6

16.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

16.4

438

2897

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

4.5

16.2

129

A12AA04

ATC

calcium carbonate; oral

6.6

16.1

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.6

15.9

205

N02AX02

ATC

tramadol; systemic, rectal

1.5

15.7

695

5192

R53

ICD-10 Finland

Malaise and fatigue

1.8

15.7

314

1903

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

15.6

4299X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Heart disease, unspecified

+∞

15.6

I30.0

ICD-10 Finland

Acute nonspecific idiopathic pericarditis

+∞

15.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

15.6

134

578

Electrophysiological Special Examination

85.7

15.6

J01MA14

ATC

moxifloxacin; systemic

2.2

15.2

152

706

I45.9

ICD-10 Finland

Conduction disorder, unspecified

45.3

15.1

R00.2

ICD-10 Finland

Palpitations

2.8

15.0

349

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.1

14.9

272

C10AA01

ATC

simvastatin; oral

1.5

14.8

671

5025

N18.8

ICD-10 Finland

Other chronic renal failure

4.3

14.8

132

SPAT1097

SPAT

Recording of ECG

1.9

14.7

213

1156

J01FA06

ATC

roxithromycin; oral

1.5

14.7

640

4750

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

14.6

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

+∞

14.6

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

14.6

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.7

14.6

105

409

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

14.6

368

H02AB07

ATC

prednisone; oral

1.9

14.5

237

1344

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

3.1

14.1

268

A98

ICPC

Health maint/preventive medicine

0.7

14.1

1449

15999

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.3

14.0

126

556

J01FF01

ATC

clindamycin; systemic

1.6

14.0

418

2835

N19

ICD-10 Finland

Unspecified kidney failure

3.7

13.9

165

3AC01

NOMESCO Finland

7.8

13.8

B01AE07

ATC

dabigatran etexilate; oral

5.1

13.8

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

4.8

13.8

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.8

13.8

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

13.5

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

+∞

13.5

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

13.5

151

738

B03XA02

ATC

darbepoetin alfa; parenteral

5.3

13.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

13.4

485

3440

UJF32

NOMESCO Finland

Coloscopy

1.6

13.4

378

2522

I49.1

ICD-10 Finland

Atrial premature depolarization

8.2

13.3

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

13.3

147

717

N18.0

ICD-10 Finland

End-stage renal disease

7.3

13.2

R55

ICD-10 Finland

Syncope and collapse

2.0

13.1

167

860

205

Kela drug reimbursment

Chronic hypertension

1.5

13.1

462

3250

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

7.9

13.1

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

6.8

13.0

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

12.9

148

731

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.4

12.9

107

R04.0

ICD-10 Finland

Epistaxis

2.3

12.7

113

497

J01MA12

ATC

levofloxacin; systemic

1.7

12.7

294

1854

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

12.7

392

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

12.7

285

I20.00

ICD-10 Finland

Unstable angina

3.7

12.5

144

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

12.5

156

796

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.1

12.5

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

12.5

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

12.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

12.3

110

485

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

12.3

104

446

J01AA02

ATC

doxycycline; systemic

1.4

12.2

1302

11356

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

12.0

236

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

5.1

12.0

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

11.8

5314

FHL

Bypass surgery for four or more vessels

8.4

11.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.5

11.6

394

K99

ICPC

Cardiovascular disease other

4.4

11.6

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.7

11.5

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

5.9

11.5

I42

ICD-10 Finland

Cardiomyopathy

+∞

11.5

I31.8

ICD-10 Finland

Other specified diseases of pericardium

+∞

11.5

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

120.6

11.4

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.6

11.4

137

Kela drug reimbursment

Uraemia requiring dialysis

7.9

11.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

11.3

207

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

11.3

119

569

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

4.0

11.3

112

K70.0

ICD-10 Finland

Alcoholic fatty liver

6.6

11.3

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

8.9

11.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

11.0

165

905

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.9

10.9

170

947

C08DB01

ATC

diltiazem; oral

2.3

10.8

416

J46

ICD-10 Finland

Status asthmaticus

3.7

10.8

127

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.3

10.8

G47.3

ICD-10 Finland

Sleep apnoea

1.6

10.7

314

2108

R00.1

ICD-10 Finland

Bradycardia, unspecified

4.4

10.6

Catheterization and pressure measurement of the left side of the heart

4.4

10.6

N06AX11

ATC

mirtazapine; oral

1.5

10.5

464

3410

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

10.5

333

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

110.5

10.4

7AX01

NOMESCO Finland

110.5

10.4

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

10.4

342

Kela drug reimbursment

Dronedarone

+∞

10.4

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

10.4

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

+∞

10.4

C07AA05

ATC

propranolol; systemic

1.6

10.4

264

1708

A46

ICD-10 Finland

Erysipelas

1.7

10.3

203

1217

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.7

10.3

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

10.3

252

1610

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

5.8

10.3

5315

FHL

Bypass surgery using a mammary artery

5.5

10.3

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.1

10.2

182

A02BC03

ATC

lansoprazole; oral

1.5

10.2

433

3155

Coronary artery bypass surgery

3.5

10.1

129

J01CA04

ATC

amoxicillin; systemic

1.4

10.1

1354

12055

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

10.1

10.0

Q21.19

ICD-10 Finland

Atrial septal defect NOS

40.2

10.0

M10.9

ICD-10 Finland

Gout, unspecified

2.2

9.9

436

C07AG02

ATC

carvedilol; oral

2.3

9.9

383

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

2.6

9.9

273

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.7

9.9

116

R03BB04

ATC

tiotropium bromide; inhalant

1.9

9.9

157

879

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

9.8

308

2095

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.7

9.8

250

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.0

9.8

131

689

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.0

9.7

183

WX722

NOMESCO Finland

PEEP

2.5

9.7

296

C08CA05

ATC

nifedipine; systemic

2.1

9.6

109

538

C10AA05

ATC

atorvastatin; oral

1.4

9.6

532

4075

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

4.3

9.6

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

9.6

256

1676

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

9.5

686

5502

N02BE01

ATC

paracetamol; systemic, rectal

1.4

9.5

1417

12763

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.5

9.5

126

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

9.5

775

6347

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

100.4

9.4

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

9.4

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

9.4

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

9.4

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

9.4

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

9.4

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

9.4

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

9.4

Initial pacemaker installation

+∞

9.4

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

9.4

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

9.3

126

666

WX882

NOMESCO Finland

High dependency care

3.3

9.3

138

N06AB04

ATC

citalopram; systemic

1.5

9.3

322

2240

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

9.3

230

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

9.3

242

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

9.2

150

846

C02EA02

ATC

2.3

9.2

344

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

9.2

275

1848

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

9.1

184

1114

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

9.1

402

2942

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

9.1

110

558

N05CD07

ATC

temazepam; oral

1.7

9.1

205

1282

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

9.1

209

1312

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

9.0

419

3098

R07.2

ICD-10 Finland

Precordial pain

3.7

9.0

100

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

9.0

510

3917

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

9.0

409

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

9.0

106

531

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.5

8.9

A11

ICPC

Chest pain NOS

2.1

8.8

101

504

J01DA01

ATC

[U] cefalexin; systemic

1.3

8.7

1035

8931

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

8.7

399

B05DA

ATC

Isotonic solutions

7.2

8.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

8.7

226

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.7

8.7

226

B01AF03

ATC

edoxaban; oral

14.1

8.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

8.5

185

1143

R51.80

ICD-10 Finland

Headache

1.7

8.5

196

1229

K29

ICPC

Cardiovascular sympt/complt other

2.7

8.5

212

N05AA02

ATC

levomepromazine; systemic

2.3

8.5

345

AP2

Catheterization of the right side of the heart

20.1

8.5

I40

ICD-10 Finland

Acute myocarditis

90.4

8.4

I45.3

ICD-10 Finland

Trifascicular block

90.4

8.4

WX002

NOMESCO Finland

Sedation and analgesia

1.5

8.4

276

1896

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

8.4

126

694

J01DB01

ATC

cefalexin; oral

1.3

8.4

1355

12211

I51.2

ICD-10 Finland

Rupture of papillary muscle, not elsewhere classified

+∞

8.3

4240B

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[PROLAPSUS VALVULAE MITRALIS (SYNDROMA BARLOW)]

+∞

8.3

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

8.3

I48.3

ICD-10 Finland

Typical atrial flutter

+∞

8.3

Catheter ablation of arrhythmia

+∞

8.3

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

8.3

Initial installation of the atrial pacemaker

+∞

8.3

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

8.3

168

1018

XF620

NOMESCO Finland

Examination of circulation with color method

10.8

8.3

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.8

8.3

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

8.3

500

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

8.1

164

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

8.1

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

33.5

8.1

Q23.11

ICD-10 Finland

Bicuspid aortic valve

22.1

8.0

WX890

NOMESCO Finland

Intesive care monitoring

6.3

8.0

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

5.9

8.0

GD2SN

NOMESCO Finland

Lung ventilation SPECT

7.8

7.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.9

7.8

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.1

7.8

GD1UN

NOMESCO Finland

Lung circulation SPECT

8.5

7.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

7.8

430

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

45.1

7.7

AS2

Ventricular pacemaker insertion VVI (R)

45.1

7.7

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

15.1

7.7

XG410

NOMESCO Finland

Flow-volume spirometry

2.4

7.7

258

A02BA04

ATC

nizatidine; systemic

1.8

7.7

124

702

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

8.0

7.6

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

7.6

304

Catheterization and pressure measurement of the right side of the heart

25.1

7.6

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

7.6

245

E87.5

ICD-10 Finland

Hyperkalaemia

4.0

7.6

ZX108

NOMESCO Finland

Inhalation

6.2

7.5

J01FA10

ATC

azithromycin; systemic

1.3

7.5

871

7431

R42

ICD-10 Finland

Dizziness and giddiness

1.5

7.5

280

1976

C08CA01

ATC

amlodipine; oral

1.4

7.5

500

3927

TK810

NOMESCO Finland

Hemofiltration

7.1

7.5

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

7.1

7.5

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

4.8

7.4

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.8

7.4

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.2

7.4

355

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

7.4

179

1142

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.4

431

3312

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

80.3

7.4

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

80.3

7.4

I44.4

ICD-10 Finland

Left anterior fascicular block

80.3

7.4

N03AX16

ATC

pregabalin; oral

1.5

7.4

311

2250

N05AH04

ATC

quetiapine; oral

1.5

7.4

241

1653

L04AA01

ATC

[U] ciclosporin; systemic

3.8

7.3

K04

ICPC

Palpitations/awareness of heart

2.6

7.3

189

N30.0

ICD-10 Finland

Acute cystitis

1.7

7.3

165

1031

SPAT1254

SPAT

Administration of medicine

1.6

7.3

202

1330

E66.8

ICD-10 Finland

Other obesity

2.3

7.3

284

AB1

AVR mechanical

+∞

7.3

250

Kela drug reimbursment

+∞

7.3

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

7.3

I40.1

ICD-10 Finland

Isolated myocarditis

+∞

7.3

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

7.3

Aortic Valve Replacement (AVR)

+∞

7.3

C01BD07

ATC

dronedarone; oral

+∞

7.3

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

7.3

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

+∞

7.3

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

7.3

AC4

MVP

+∞

7.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

9.4

7.3

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

9.4

7.3

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.0

7.3

AN3

Balloon angioplasty and metallic stent

2.8

7.3

154

WX740

NOMESCO Finland

Nitrogen oxide therapy

15.8

7.2

R03BA05

ATC

fluticasone; inhalant

1.5

7.2

257

1798

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

7.2

214

1434

R11

ICD-10 Finland

Nausea and vomiting

1.8

7.2

113

635

B05DB

ATC

Hypertonic solutions

7.3

7.2

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

7.2

459

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

7.2

122

704

A02BC05

ATC

esomeprazole; systemic

1.3

7.2

572

4618

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

3.8

7.2

C01BA03

ATC

disopyramide; systemic

20.1

7.1

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

7.9

7.1

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.1

7.1

117

B01AF01

ATC

rivaroxaban; oral

1.8

7.1

112

631

I20.01

ICD-10 Finland

Unstable angina

2.9

7.1

144

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

12.1

7.1

K01

ICPC

Heart pain

4.5

7.1

WX730

NOMESCO Finland

Conventional respirator

3.7

7.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

7.0

276

A02BC01

ATC

omeprazole; systemic

1.4

6.9

403

3094

P01AB01

ATC

metronidazole; oral, rectal

1.3

6.9

537

4316

I97.0

ICD-10 Finland

Postcardiotomy syndrome

13.8

6.9

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

6.9

241

M05BA04

ATC

alendronic acid; oral

1.8

6.8

108

608

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

6.8

149

927

J01MA02

ATC

ciprofloxacin; systemic

1.3

6.8

588

4798

C02AC05

ATC

moxonidine; oral

2.3

6.8

267

N05BA12

ATC

alprazolam; oral

1.7

6.8

137

831

Q21.10

ICD-10 Finland

Persistent ostium secundum

9.3

6.8

C08CA07

ATC

nisoldipine; oral

4.0

6.8

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

40.2

6.8

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

40.2

6.8

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

16.7

6.7

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

16.7

6.7

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.2

6.7

314

SPAT1104

SPAT

Monitoring of emergency patient

2.0

6.7

440

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

6.7

110

625

F19.0

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, acute intoxication

22.6

6.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

6.6

158

1002

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.8

6.6

196

Kela drug reimbursment

Paricalcitol and cinacalcet

12.3

6.6

J81

ICD-10 Finland

Pulmonary oedema

8.7

6.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.0

6.5

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

5.7

6.4

C09AA04

ATC

perindopril; oral

2.0

6.4

379

I45.6

ICD-10 Finland

Pre-excitation syndrome

70.0

6.4

5311

FHL

Bypass surgery in one vein

70.0

6.4

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

7.4

6.4

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

14.3

6.4

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

6.4

161

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.5

6.4

N05AN01

ATC

lithium; oral

2.7

6.4

144

C10AA03

ATC

pravastatin; oral

1.9

6.4

497

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

6.3

123

739

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.6

6.3

M79.6

ICD-10 Finland

Pain in limb

1.3

6.3

480

3839

Z49.2

ICD-10 Finland

Other dialysis

5.5

6.3

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

6.3

170

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

6.3

327

I45.0

ICD-10 Finland

Right fascicular block

18.1

6.3

5AB14

NOMESCO Finland

18.1

6.3

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

6.2

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

6.2

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

6.2

5284

FHL

Mitral defect correction with flap prosthesis or graft

+∞

6.2

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

6.2

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

6.2

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

6.2

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

+∞

6.2

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

6.2

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

+∞

6.2

FM1AD

NOMESCO Finland

CT of heart

+∞

6.2

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

6.2

4291A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Myocardial degeneration

+∞

6.2

AC2

MVR bio

+∞

6.2

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

6.2

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

6.2

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

6.2

AQ2

Electrophysiological electroanatomical examination

+∞

6.2

I30.8

ICD-10 Finland

Other forms of acute pericarditis

+∞

6.2

J96.1

ICD-10 Finland

Chronic respiratory failure

3.0

6.2

106

A07AA02

ATC

nystatin; oral

1.9

6.2

450

B04AB02

ATC

2.9

6.2

127

B01AB04

ATC

dalteparin; parenteral

2.0

6.2

343

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

6.2

154

990

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

6.2

571

4691

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

6.2

388

3013

B01AC07

ATC

dipyridamole; systemic

1.9

6.2

457

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

6.1

277

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.7

6.1

J01FA09

ATC

clarithromycin; systemic

1.3

6.1

430

3397

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.9

6.1

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

2.6

6.1

161

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

6.0

272

1990

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

6.0

108

632

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

6.0

146

932

V03AE03

ATC

lanthanum carbonate; oral

10.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

924

3110

4.33

242.51

6.2

1.8

ng/l

1786.9

679.6

6.72

816

2483

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

205

302

7.36

134.18

3.8

1.9

mg/l

10.8

10.3

0.34

195

280

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

347

839

4.70

133.95

5.1

1.9

ng/l

315.1

89.9

8.23

319

727

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

369

947

4.46

131.97

3.0

1.8

ug/l

11.3

6.2

1.99

317

807

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

639

2493

3.18

121.51

8.5

2.8

ng/l

831.2

520.6

1.03

567

1851

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

997

5220

2.63

106.19

6.6

2.7

ng/l

504.1

49.0

0.95

775

3423

(3022217) INR in Platelet poor plasma by Coagulation assay

400

1285

3.57

102.85

36.7

9.5

inr

1.6

1.1

4.87

232

(3027456) Digoxin [Moles/volume] in Serum or Plasma

25.76

100.21

3.0

1.9

nmol/l

0.9

0.8

0.89

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

235

570

4.48

89.13

3.5

1.7

u/l

35.4

40.4

2.99

208

514

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

166

306

5.77

86.63

6.7

2.8

u/ml

0.3

0.23

116

157

(3020779) Urea [Moles/volume] in Serum or Plasma

337

1128

3.33

80.11

16.0

6.6

mmol/l

10.6

8.7

4.12

316

1073

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

434

1685

2.95

79.96

3.9

2.2

22.3

24.5

2.45

379

1432

(3022948) Iron [Moles/volume] in Serum or Plasma

479

1970

2.82

79.23

3.9

2.2

umol/l

12.3

14.0

5.26

451

1814

(3032080) INR in Blood by Coagulation assay

949

5390

2.31

78.38

15.2

4.5

inr

1.4

1.1

12.75

257

1507

(3004789) Transferrin [Mass/volume] in Serum or Plasma

452

1814

2.86

78.21

3.9

2.1

g/l

2.2

2.3

3.37

419

1667

(3012095) Magnesium [Moles/volume] in Serum or Plasma

480

2115

2.61

68.37

6.6

3.4

mmol/l

0.8

0.04

454

1972

(3023368) Bacteria identified in Blood by Culture

719

3901

2.24

63.50

5.6

3.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

136

284

5.03

61.55

1.6

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

275

4.95

57.93

1.6

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

458

2136

2.43

56.83

2.1

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

586

3069

2.23

55.28

3.1

1.6

mg/l

1.1

1.2

0.83

436

2304

(3018677) aPTT in Platelet poor plasma by Coagulation assay

432

1993

2.44

54.72

4.9

2.0

31.2

29.1

6.85

417

1937

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

103

199

5.37

50.85

1.7

1.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

143

371

4.05

49.12

1.8

1.5

g/l

1.2

0.38

134

347

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

126

300

4.39

48.49

1.9

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

138

354

4.09

48.13

1.9

1.5

g/l

0.2

0.29

128

333

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

120

278

4.50

47.81

1.9

1.5

u/ml

106.3

113.9

0.27

(3003458) Phosphate [Moles/volume] in Serum or Plasma

382

1774

2.39

47.14

12.2

5.4

mmol/l

1.1

1.0

7.34

356

1636

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

121

298

4.23

44.54

1.5

1.3

u/ml

247.2

250.3

0.03

178

(3000991) Gas panel - Venous blood

271

1102

2.66

44.20

12.9

7.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

291

4.22

43.35

6.8

5.8

iu/ml

774.3

815.2

0.03

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

124

318

4.07

43.23

1.5

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

323

1455

2.42

42.39

2.1

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

163

5.38

42.29

1.5

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

8.62

42.15

25.6

27.2

ug/l

101.8

128.1

1.58

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

698

4249

1.93

41.89

3.2

2.0

u/l

587.4

250.1

0.80

671

3988

(44790048)

133

5.88

41.69

1.4

1.7

—

(44790049)

133

5.88

41.69

1.4

1.7

—

(44806118)

133

5.88

41.69

1.4

1.7

—

(44790047)

133

5.88

41.69

1.4

1.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

317

1433

2.41

41.21

10.3

7.1

kpa

5.1

0.09

297

1366

(3027801) Oxygen [Partial pressure] in Arterial blood

317

1434

2.41

41.15

10.2

7.1

kpa

12.2

12.8

0.91

297

1368

(3003396) Base excess in Arterial blood by calculation

317

1434

2.41

41.15

10.5

7.1

mmol/l

1.3

0.8

1.31

254

1091

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

135

5.79

41.04

1.5

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

322

1481

2.37

40.21

5.5

4.0

u/l

251.7

236.7

0.81

301

1393

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

316

1448

2.37

39.77

2.0

1.6

—

(42870588) Differential panel, method unspecified - Blood

793

5109

1.85

39.41

9.1

5.9

—

(3013115) Eosinophils [#/volume] in Blood

1105

7897

1.78

38.62

9.8

6.1

e9/l

0.2

0.36

983

6862

(3006315) Basophils [#/volume] in Blood

1075

7624

1.78

38.55

9.4

5.8

e9/l

0.0

0.18

943

6533

(3001604) Monocytes [#/volume] in Blood

1070

7586

1.78

38.34

9.5

5.7

e9/l

0.6

4.24

939

6497

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1087

7742

1.78

38.34

7.8

6.1

umol/l

13.0

11.7

1.70

1027

7332

(3019198) Lymphocytes [#/volume] in Blood

1098

7854

1.77

38.06

9.3

5.8

e9/l

1.9

2.0

0.10

971

6850

(3009445) Proteinase 3 Ab [Units/volume] in Serum

165

566

3.06

36.78

1.7

1.5

u/ml

7.3

20.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1037

7348

1.76

36.70

11.6

5.9

mmol/l

1.2

4.98

892

6197

(3013826) Glucose [Moles/volume] in Serum or Plasma

1191

8795

1.75

36.28

7.7

4.1

mmol/l

6.7

0.07

1144

8163

(3006504) Eosinophils/100 leukocytes in Blood

1010

7127

1.75

36.08

9.8

6.0

2.8

2.9

0.56

969

6612

(3019069) Monocytes/100 leukocytes in Blood

1014

7169

1.75

35.93

10.0

6.3

8.9

8.7

1.08

975

6688

(3016502) Oxygen saturation in Arterial blood

281

1281

2.36

35.60

11.2

7.6

96.1

0.02

268

1231

(3002032) Base excess in Venous blood by calculation

276

1251

2.37

35.42

6.6

3.6

mmol/l

1.6

1.7

0.30

233

974

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

948

6596

1.75

35.38

10.9

5.3

mmol/l

1.2

5.47

889

5928

(3022096) Basophils/100 leukocytes in Blood

985

6929

1.75

35.36

9.8

6.1

0.6

0.7

1.90

944

6439

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

207

4.43

35.26

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

259

1147

2.42

34.99

11.5

6.7

mmol/l

1.2

1.4

1.44

251

1091

(3002030) Lymphocytes/100 leukocytes in Blood

1036

7408

1.74

34.95

9.8

6.1

26.1

28.4

8.85

986

6877

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

224

4.24

34.36

3.2

3.4

u/ml

223.3

2606.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

337

1681

2.18

34.35

10.6

6.4

mmol/l

104.6

104.3

0.64

329

1645

(3033658) Prothrombin time (PT) actual/Normal

616

3821

1.84

33.58

5.9

3.7

84.5

93.6

13.77

598

3733

(3021447) Carbon dioxide [Partial pressure] in Venous blood

272

1253

2.33

33.56

6.6

3.5

kpa

6.0

5.8

2.37

266

1214

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

131

415

3.29

33.34

5.0

2.2

91.2

92.6

0.28

126

392

(3018010) Neutrophils/100 leukocytes in Blood

1016

7303

1.71

33.02

9.6

5.9

59.4

56.7

10.14

967

6821

(3036489) Thrombin time

146

498

3.06

32.83

4.5

2.1

21.8

21.0

0.76

133

443

(3048929) Epstein Barr virus Ab [Presence] in Serum

147

507

3.03

32.42

1.5

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

120

368

3.39

32.16

5.3

2.6

g/l

3.7

3.6

0.45

112

354

(3002173) Hemoglobin [Mass/volume] in Arterial blood

260

1198

2.32

32.00

11.2

8.0

g/l

122.1

124.2

0.79

252

1150

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

169

644

2.75

31.04

7.1

4.1

mmol/l

24.1

24.0

0.14

158

585

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

148

526

2.94

30.94

2.1

1.8

ug/l

2.0

2.1

0.05

141

471

(3018418) pH of Serum or Plasma

661

4299

1.76

30.19

7.0

3.5

7.4

0.16

117

787

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

555

3444

1.81

29.67

2.9

2.0

mg/l

3.0

2.8

0.84

482

2888

(3037522) Nuclear Ab [Titer] in Serum

348

1864

2.02

29.07

1.4

1.3

titre

435.2

528.0

0.67

365

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

177

4.29

28.30

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

153

4.55

28.09

1.5

1.4

—

(40758558) Short blood count panel - Blood

588

3765

1.76

28.02

9.9

6.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

213

952

2.37

28.01

1.8

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

227

1049

2.29

27.62

5.7

3.1

kpa

4.9

4.6

1.49

219

1015

(3001122) Ferritin [Mass/volume] in Serum or Plasma

851

6059

1.65

27.12

4.4

2.5

ug/l

154.0

144.0

0.46

801

5577

(3013650) Neutrophils [#/volume] in Blood by Automated count

1158

8902

1.62

26.98

12.4

9.1

e9/l

4.4

4.1

4.33

1024

7720

(3042733) HLA Ab [Presence] in Serum

7.56

26.75

4.9

4.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

184

799

2.42

25.77

1.5

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

254

1268

2.13

25.48

2.5

2.2

nmol/l

382.2

371.9

0.32

230

1172

(3027945) Reticulocytes/100 erythrocytes in Blood

289

1518

2.04

25.29

2.9

2.5

1.8

1.7

0.90

262

1329

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

106

5.09

25.18

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

110

376

3.02

24.63

4.5

3.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

142

566

2.61

23.82

2.0

1.6

g/l

1.6

1.5

0.02

117

485

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

157

665

2.46

23.19

14.5

9.1

mmol/l

24.3

24.1

0.27

147

622

(3019060) Gas panel - Arterial blood

177

793

2.34

23.07

5.8

4.9

—

(3024471) HLA-A [Type]

6.76

22.96

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

212

3.62

22.79

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

132

4.40

22.74

1.6

1.8

—

(3024932) HLA-DR beta [Type]

6.63

22.57

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

397

2.86

22.35

1.3

1.1

—

(3009343) pH of Capillary blood

186

867

2.25

22.07

4.9

3.4

7.4

0.29

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

181

837

2.26

21.89

4.9

3.4

mmol/l

1.6

1.4

0.24

143

594

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

111

409

2.80

21.71

1.5

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

186

876

2.22

21.52

4.9

3.4

kpa

5.1

0.08

175

804

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

118

4.49

21.29

1.6

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

3.87

21.19

1.4

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

214

3.49

21.02

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

291

1677

1.84

19.09

2.8

2.9

umol/l

9.0

0.00

259

1483

(3024561) Albumin [Mass/volume] in Serum or Plasma

851

6448

1.51

18.83

7.1

4.6

g/l

34.5

35.9

8.60

783

5973

(3005719) IgG [Mass/volume] in Serum or Plasma

215

1130

2.00

18.60

2.1

2.6

g/l

10.5

10.6

0.12

195

1030

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

198

1012

2.05

18.51

6.7

3.6

ng/l

122.1

79.2

3.72

178

877

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

155

3.75

18.37

8.4

5.8

mg/l

11.0

0.01

143

(3042936) Bacteria identified in Isolate by Culture

331

2005

1.76

18.35

2.4

1.9

—

(3051651) Icteric interference index of Serum or Plasma

4.94

18.04

4.1

3.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

309

1844

1.78

18.02

2.0

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

636

4564

1.55

17.94

4.3

3.1

e6/l

45.3

79.1

1.26

521

3503

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

680

4961

1.53

17.75

3.6

3.2

u/l

45.0

36.3

1.01

637

4704

(3028026) IgM [Mass/volume] in Serum or Plasma

177

887

2.08

17.44

1.4

1.9

g/l

1.3

1.4

0.26

159

810

(3030467) Casts [#/volume] in Urine by Automated count

586

4167

1.55

17.09

4.2

3.0

e6/l

0.5

0.4

0.30

473

3116

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

147

691

2.20

17.07

16.0

9.7

—

(3024928) Oxygen saturation in Venous blood

246

3.03

16.81

5.5

3.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

203

1083

1.96

16.80

2.8

2.5

g/l

64.6

67.2

3.84

182

987

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

161

3.54

16.65

2.3

2.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

160

788

2.11

16.50

1.8

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

204

1098

1.94

16.45

2.6

2.5

e9/l

75.3

66.8

2.11

151

814

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

153

3.59

16.41

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.38

16.40

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

149

718

2.15

16.26

3.6

3.5

pmol/l

4.3

4.7

4.71

131

640

(3008152) Bicarbonate [Moles/volume] in Arterial blood

159

787

2.10

16.19

8.6

6.6

mmol/l

24.8

24.4

0.50

151

726

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

370

2390

1.65

16.06

3.5

2.9

e6/l

2.2

2.1

0.08

209

1293

(3026782) Osmolality of Urine

441

2975

1.60

16.06

3.4

2.6

mosm/kgh2o

534.4

572.4

3.40

391

2515

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.73

15.88

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

374

2.58

15.86

1.8

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

272

2.86

15.74

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

272

2.86

15.74

1.4

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

643

4733

1.50

15.73

3.2

2.5

u/l

56.7

57.9

0.32

605

4347

(3015235) Bicarbonate [Moles/volume] in Capillary blood

314

2.70

15.49

3.2

2.6

mmol/l

24.3

24.6

0.23

276

(46235355) HIV 1 and 2 tests - Meaningful Use set

414

2777

1.60

15.38

2.2

1.9

—

(3000850) Epithelial cells [#/volume] in Urine

457

3140

1.57

15.31

3.3

2.4

e6/l

4.7

4.9

0.14

417

2733

(1616796) Gas panel - Central venous blood

260

2.87

15.26

4.4

2.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

382

2522

1.62

15.13

3.4

2.7

e6/l

1.4

1.2

0.34

221

1414

(3018095) Leukocytes [#/volume] in Urine

702

5304

1.47

14.92

4.9

3.5

e6/l

56.3

102.7

1.78

548

3750

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

339

2187

1.65

14.70

1.9

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

212

1201

1.84

14.58

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

133

3.59

14.34

4.5

3.0

—

(3021589) Normoblasts [#/volume] in Blood

864

6826

1.43

14.33

15.1

8.5

e9/l

0.0

0.63

695

5572

(3023199) Leukocytes [#/volume] in Pleural fluid

4.07

14.26

1.4

1.2

e6/l

1598.0

2646.9

0.69

(3007853) Bacteria identified in Skin by Aerobe culture

275

1698

1.70

14.07

2.1

1.6

—

(3022313) Gas panel - Capillary blood

134

656

2.11

14.05

5.2

3.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.24

13.88

1.4

1.2

e6/l

71514.5

68500.0

0.02

(40767503) Oxygen content in Capillary blood by calculation

257

2.78

13.86

2.7

2.3

16.2

16.8

0.56

129

(3013512) EKG study

564

4134

1.48

13.79

5.0

3.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

401

2.40

13.72

2.0

3.2

mg/l

102.5

179.5

0.22

332

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

401

2.40

13.72

2.0

3.2

mg/l

32.7

71.1

1.19

332

(40760888) Immunoglobulin light chains.free panel - Serum

300

2.62

13.59

2.1

3.4

—

(36304419) Bacteria [Presence] in Urine

555

4065

1.48

13.59

4.1

2.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

391

2.41

13.54

2.0

3.2

ratio

3.2

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

109

500

2.24

13.46

1.4

—

(3045788) Cell count panel - Pleural fluid

4.49

13.30

1.4

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

622

4676

1.46

13.28

3.0

2.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

127

3.51

13.06

1.2

1.3

titre

98.0

220.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

495

3569

1.49

13.04

2.8

2.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

417

2.33

13.01

7.3

4.3

mg/l

1.8

1.3

3.19

393

(3044889) 12 lead EKG panel

1268

10826

1.39

12.88

5.8

3.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

219

2.83

12.62

1.3

1.2

u/ml

6.6

3.1

0.36

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

222

1334

1.74

12.49

2.4

g/l

0.2

0.98

204

1251

(3004588) Protein electrophoresis panel - Serum or Plasma

166

915

1.88

12.44

1.8

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1390

12091

1.39

12.36

10.4

7.0

u/l

79.6

79.0

0.16

1328

11294

(3031040) Bacteria [#/volume] in Urine by Automated count

1167

9868

1.38

12.34

5.0

4.0

e6/l

436.8

2017.0

1.07

150

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

234

2.74

12.24

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

104

3.70

12.21

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

104

3.70

12.21

1.7

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

104

3.70

12.21

1.7

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

228

1389

1.71

12.21

3.0

2.5

u/l

35.0

74.1

0.60

202

1205

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.39

12.15

1.5

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.39

12.15

1.5

1.6

—

(3021901) Oxygen saturation in Capillary blood

224

2.77

12.11

3.0

2.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

370

2.35

11.89

4.9

3.8

mmol/l

4.0

3.9

1.09

343

(3012441) Differential panel - Pleural fluid

4.09

11.85

1.4

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

285

2.54

11.84

3.1

umol/l

31.6

38.5

1.11

249

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

269

2.57

11.68

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

117

584

2.06

11.68

2.1

1.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

405

2.27

11.67

1.6

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

116

579

2.06

11.58

5.7

3.7

mmol/l

25.0

24.7

0.53

107

539

(3026493) Urate [Moles/volume] in Serum or Plasma

522

3898

1.44

11.28

3.7

2.4

umol/l

1480.8

5195.7

3.24

463

3417

(3006184) Hemoglobin [Mass/volume] in Capillary blood

280

2.51

11.26

2.4

2.0

g/l

125.1

133.7

1.74

189

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.94

11.20

1.0

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

394

2.26

11.12

1.4

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

433

2.20

11.12

2.5

2.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.18

11.07

1.2

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

132

3.22

10.96

1.4

1.2

g/l

7.7

6.9

0.58

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.84

10.95

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.12

10.87

1.2

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

229

2.62

10.56

1.5

1.8

g/l

0.9

0.8

0.10

173

(3020891) Body temperature

101

498

2.08

10.45

7.0

4.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

163

947

1.78

10.31

1.4

1.3

au/ml

40.0

58.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

132

3.14

10.30

1.4

1.2

g/l

2.8

3.1

0.36

(3024139) IgG subclass 3 [Mass/volume] in Serum

132

3.14

10.30

1.4

1.2

g/l

0.4

0.24

(4062490)

132

3.14

10.30

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.56

10.24

1.1

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.56

10.24

1.1

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

186

1125

1.71

10.21

3.3

2.5

ml/min/173m2

52.5

71.0

5.41

452

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.82

10.14

7.3

5.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

7.18

10.13

7.2

5.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

223

2.60

10.06

1.3

1.2

u/ml

1.5

4.1

1.16

(40760892) CBC W Ordered Manual Differential panel - Blood

457

3401

1.43

9.91

5.8

4.5

—

(3010813) Leukocytes [#/volume] in Blood

1741

18637

0.71

9.89

34.7

17.2

e9/l

7.2

6.7

8.43

1698

17990

(3007164) IgA [Mass/volume] in Serum or Plasma

401

2914

1.46

9.88

1.5

g/l

2.6

2.5

0.40

264

1820

(3004451) EKG impression Narrative

4.27

9.83

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1742

18635

0.71

9.71

34.9

17.2

g/l

134.8

138.1

14.87

1720

18294

(3012501) Base excess in Blood by calculation

276

2.39

9.67

5.4

3.3

mmol/l

2.5

2.3

0.22

174

(3026361) Erythrocytes [#/volume] in Blood

1742

18630

0.71

9.63

34.7

17.1

e12/l

4.5

4.6

10.63

1693

17982

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

172

1035

1.72

9.63

2.5

2.4

au/ml

33.4

20.5

—

(3024731) MCV [Entitic volume]

1742

18628

0.71

9.60

34.5

17.1

91.1

90.7

2.06

1718

18290

(3035941) MCH [Entitic mass]

1742

18627

0.71

9.58

34.5

17.1

30.3

0.31

1718

18287

(3034426) Prothrombin time (PT)

5.03

9.56

1.1

1.3

—

(3010421) pH of Blood

336

2.24

9.45

5.5

3.1

7.4

0.01

269

(4268621)

150

2.90

9.44

2.2

2.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

103

3.33

9.44

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

103

3.33

9.44

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

103

3.33

9.44

1.3

1.1

—

(3007461) Platelets [#/volume] in Blood

1742

18612

0.72

9.34

34.7

17.2

e9/l

249.6

248.9

0.15

1702

18027

(3037467) Urinalysis macro (dipstick) panel - Urine

1222

10664

1.32

9.28

5.2

3.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

105

549

1.96

9.26

1.9

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1512

16493

0.75

9.18

5.2

4.5

mmol/l

2.6

2.8

14.02

1413

15158

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

106

3.24

9.03

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

106

3.24

9.03

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

106

3.24

9.03

1.3

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

112

609

1.88

8.81

8.9

1.4

mg/l

2.4

4.8

1.53

105

426

(3014148) Varicella zoster virus Ab [Titer] in Serum

174

2.68

8.72

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1308

11579

1.31

8.67

5.2

3.7

mm/h

14.0

11.0

8.43

1214

10677

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

486

1.97

8.59

1.6

iu/ml

4.7

0.2

0.46

(3007566) Smooth muscle Ab [Titer] in Serum

424

2.04

8.58

1.1

1.3

titre

51.7

81.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.36

8.48

1.5

1.9

—

(40768806) Pleura Pathology biopsy report

3.25

8.07

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

230

2.38

8.03

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

834

7021

1.30

7.81

4.4

3.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1491

16175

0.77

7.69

4.8

4.1

mmol/l

4.4

4.7

19.38

1399

14958

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.74

7.62

1.9

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.74

7.62

1.8

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.74

7.62

1.8

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.74

7.62

1.8

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

486

1.91

7.60

1.5

2.0

g/l

10.1

10.3

0.13

411

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

275

2.21

7.56

1.3

1.1

—

11.0

—

(3026008) Bacteria identified in Urine by Culture

516

4079

1.34

7.54

3.4

3.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

329

2.10

7.48

1.2

1.1

u/ml

5.1

2.6

—

(3011412) CD3 cells [#/volume] in Blood

131

2.78

7.38

2.4

2.5

e9/l

1.1

1.2

0.06

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1481

16050

0.77

7.34

4.8

4.0

mmol/l

1.3

1.4

10.35

1382

14759

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

332

2.08

7.31

1.2

u/ml

34.9

11.6

0.72

(4306422)

215

2.35

7.31

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

203

2.39

7.28

1.4

1.2

—

(4035726)

194

1293

1.55

7.23

1.8

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

199

2.39

7.12

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

250

2.23

7.09

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

244

2.24

7.06

1.2

u/ml

10.9

42.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.05

7.04

2.0

2.1

12.4

12.9

0.08

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

147

2.61

6.95

3.7

4.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.27

6.75

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

514

1.82

6.71

1.5

2.0

g/l

3.7

3.9

0.35

369

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

514

1.82

6.71

1.5

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

514

1.82

6.71

1.5

2.0

g/l

7.3

0.09

385

(40768446) Kidney Pathology biopsy report

3.52

6.71

2.2

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.71

6.68

4.3

4.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

219

1523

1.48

6.68

4.0

2.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

286

2.09

6.50

2.4

3.7

58.6

56.3

0.87

286

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.02

6.50

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

254

2.15

6.43

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

166

2.43

6.36

1.8

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.07

6.35

1.2

1.8

—

(3035880) pH of Pleural fluid

4.07

6.35

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

480

1.82

6.31

1.2

u/ml

0.2

0.9

0.93

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.85

6.25

2.4

3.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

162

2.43

6.20

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

181

2.34

6.16

1.3

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.14

6.16

1.2

—

(3022145) Colonoscopy Study observation

234

1677

1.44

6.12

1.5

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

183

1250

1.50

6.10

4.9

4.2

1.1

0.8

0.68

355

(3030905) Polymorphonuclear cells [#/volume] in Blood

280

2.06

6.09

2.2

3.5

e9/l

4.3

4.0

0.50

280

(40761535) Cells panel - Urine sediment

179

1218

1.51

6.08

4.2

3.3

—

(3028433) Virus identified in Specimen by Culture

3.88

5.98

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

317

1.98

5.95

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

139

899

1.58

5.94

1.3

u/ml

302.1

258.1

0.21

127

824

(3025941) Bacteria identified in Stool by Culture

129

820

1.61

5.93

1.4

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

528

1.75

5.89

6.8

5.3

0.9

0.33

497

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

11.15

5.79

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

180

2.30

5.79

1.3

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

531

1.74

5.78

6.1

5.3

2.0

1.6

0.41

500

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.62

5.75

1.7

2.5

u/ml

257.4

776.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

307

1.98

5.75

1.4

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

207

2.20

5.70

1.2

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

103

2.74

5.69

2.0

2.1

—

1.9

—

(3003181) Sodium [Moles/volume] in Urine

214

2.17

5.67

1.2

1.3

mmol/l

54.3

64.8

1.09

173

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

719

6127

1.25

5.66

2.8

2.2

nmol/l

75.1

76.1

0.38

651

5473

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

310

1.96

5.60

1.3

1.4

—

(3011648) Oxygen content in Venous blood

105

2.69

5.50

4.3

3.9

11.4

11.1

0.15

105

(3019768) Coxiella burnetii Ab [Presence] in Serum

16.05

5.41

1.1

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

148

2.39

5.39

10.0

4.6

mmol/l

6.3

7.7

2.19

120

(3000093) Morphology [Interpretation] in Blood Narrative

130

2.48

5.37

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

180

2.24

5.36

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.56

5.32

2.2

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.56

5.32

2.1

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.56

5.32

2.1

2.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.02

5.26

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

4.63

5.25

2.0

mmol/l

1.2

0.21

(3008536) Aspergillus sp Ab [Presence] in Serum

4.63

5.25

1.2

2.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.63

5.25

1.9

1.8

—

(3047181) Lactate [Moles/volume] in Blood

401

1.79

5.08

8.3

6.4

mmol/l

1.4

1.3

0.48

346

(3024891) Influenza virus A+B Ag [Presence] in Specimen

394

1.80

5.07

1.3

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

451

5454

0.78

5.03

3.5

4.1

21.9

21.8

0.03

179

2595

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.80

5.01

1.3

1.0

89.8

88.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

179

2.20

5.00

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

179

2.20

5.00

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

309

2398

1.33

4.99

1.2

1.3

iu/ml

58.6

34.1

0.78

752

(3011397) Hemoglobin [Presence] in Urine by Test strip

423

3428

1.29

4.98

4.3

3.3

—

(3018572) Chloride [Moles/volume] in Blood

281

1.94

4.98

9.7

7.8

mmol/l

103.9

105.5

1.04

251

(3039000) Anion gap in Blood

281

1.94

4.98

9.7

7.8

mmol/l

11.6

11.2

0.30

251

(3048689) Calprotectin [Mass/mass] in Stool

251

1888

1.37

4.97

2.8

2.5

ug/g

242.3

142.1

2.31

201

1502

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

154

2.29

4.96

1.7

1.3

nmol/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

181

2.17

4.88

1.3

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

349

2767

1.31

4.84

1.9

1.7

nmol/l

1174.9

1128.5

0.42

275

2095

(1761868) Lipid panel - Serum or Plasma

508

6034

0.80

4.83

3.1

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1447

15467

0.82

4.76

4.5

3.6

mmol/l

1.4

1.3

1.41

1348

14127

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

380

1.79

4.75

1.7

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

245

1.98

4.69

1.6

1.7

—

(3042631) Mycobacterium sp identified in Specimen

179

2.14

4.60

2.0

2.9

—

(3019977) pH of Arterial blood

2.91

4.60

4.9

3.0

7.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

407

1.74

4.57

1.3

2.0

g/l

37.0

38.3

0.96

351

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

14.03

4.57

1.4

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

476

1.68

4.54

1.6

2.0

g/l

3.3

3.1

0.79

376

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.84

4.53

1.2

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

579

6742

0.81

4.53

3.8

4.7

ug/l

1.9

3.4

1.73

513

6096

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

386

1.76

4.52

1.3

2.1

g/l

0.0

0.43

357

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

364

1.78

4.51

1.3

2.1

g/l

0.0

0.49

337

(3021788) Differential panel - Synovial fluid

249

1.95

4.50

1.7

1.6

—

(3044941) Cell count panel - Synovial fluid

229

1.98

4.45

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

175

2.13

4.44

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.70

4.41

1.9

1.5

u/l

2.4

3.7

0.36

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

360

1.77

4.38

1.3

2.1

g/l

0.0

0.00

336

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

119

2.37

4.32

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

151

2.20

4.30

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

239

1.94

4.30

1.1

1.3

u/l

14.6

45.1

1.79

199

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.97

4.28

1.1

iu/ml

194.0

236.0

0.29

(3036525) Urea [Moles/time] in 24 hour Urine

11.69

4.27

1.9

4.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

590

5051

1.23

4.25

4.6

3.3

mmol/l

2.3

2.4

3.87

507

4400

(3037756) Immunofixation for Serum or Plasma

276

1.87

4.23

1.5

—

(3037121) Protein [Mass/volume] in Urine

494

1.64

4.22

3.7

3.6

g/l

0.5

0.4

0.57

230

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

102

2.47

4.21

2.6

2.7

e6/l

425.4

653.7

1.19

(3002179) Metamyelocytes/100 leukocytes in Blood

158

1131

1.43

4.21

4.8

4.0

0.6

0.5

0.18

257

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

441

1.68

4.18

1.5

2.1

g/l

0.4

1.2

1.83

382

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.75

4.18

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

140

2.23

4.18

1.1

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.36

4.08

1.2

1.1

92.0

70.6

—

(3000494) Fungus identified in Specimen by Culture

230

1761

1.34

4.08

1.6

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

3.35

4.04

7.3

5.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1476

15660

0.83

4.03

4.7

4.2

mmol/l

6.0

5.9

0.90

1349

14192

(3014891) Appearance of Pleural fluid

10.02

4.01

1.4

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.44

3.97

2.7

e9/l

0.2

0.17

(3017704) Immunofixation for Urine

2.73

3.92

1.6

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.73

3.92

1.5

3.8

umol/l

80.7

123.4

—

(3035350) Ketones [Presence] in Urine by Test strip

844

7528

1.19

3.90

4.3

3.3

estimate

0.0

0.00

153

1363

(3044927) Protein electrophoresis panel - Urine

138

2.19

3.89

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

7.29

3.86

1.1

1.2

—

(3000492) Spirometry study

205

1557

1.35

3.85

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

324

3958

0.79

3.83

2.7

2.9

ug/l

0.8

0.01

200

2523

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

114

1626

0.68

3.81

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

208

1.94

3.77

1.8

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

8.77

3.77

1.0

u/l

17.6

5.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

12.02

3.76

8.2

4.2

—

(3015736) pH of Urine

673

5899

1.20

3.74

4.1

3.1

—

5.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1686

17631

0.83

3.72

14.7

9.3

u/l

31.5

27.9

1.91

1634

16933

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

4.01

3.69

2.1

2.4

mmol/l

1.2

—

(3036603) Volume of Urine

2.48

3.63

1.7

1.3

1660.6

1617.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.26

3.62

5.5

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

117

2.24

3.57

2.7

2.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

161

1192

1.38

3.57

5.3

4.2

0.1

0.42

330

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

330

1.71

3.56

1.8

iu/l

3.0

5.3

2.00

122

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.17

3.50

4.1

6.9

mmol/l

4.6

6.2

—

(3000060) B lymphocytes [#/volume] in Blood

3.18

3.49

2.3

2.4

e6/l

328.3

137.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

112

2.25

3.48

3.2

2.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

393

3292

1.23

3.43

1.3

u/ml

1.7

1.5

0.09

853

(3008295) Osmolality of Serum or Plasma

146

2.07

3.41

1.2

1.5

mosm/kgh2o

291.7

284.0

0.46

111

(3009261) Glucose [Presence] in Urine by Test strip

847

7623

1.18

3.41

4.4

3.3

estimate

0.0

0.80

149

1333

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.51

3.37

1.2

ratio

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.11

3.37

1.2

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1242

11534

1.17

3.36

4.2

3.5

pmol/l

14.9

14.7

0.99

1152

10381

(40757373) Influenza virus identified in Isolate

3.45

3.33

1.4

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1093

0.65

3.32

1.3

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.03

3.25

1.5

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.75

3.23

1.2

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

220

1.83

3.23

7.5

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.59

3.21

1.5

2.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

244

1.78

3.15

3.0

3.3

1.8

1.3

0.39

188

(3021601) Nitrite [Presence] in Urine by Test strip

834

7534

1.17

3.15

5.9

4.6

estimate

0.0

0.50

158

1396

(3029075) Extractable nuclear Ab panel - Serum

2.96

3.13

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

453

1.56

3.13

1.4

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.51

3.11

1.1

91.3

96.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.51

3.11

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.24

3.05

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.69

3.05

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.44

3.04

1.8

2.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.90

3.02

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.30

2.99

1.1

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

459

1.54

2.97

1.4

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

341

1.63

2.95

2.0

1.7

e6/l

14620.4

13305.0

0.12

242

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.34

2.90

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

108

2.14

2.90

1.0

1.1

—

(3025159) Blasts/100 leukocytes in Blood

148

1122

1.34

2.87

5.2

4.2

0.0

0.1

1.53

267

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.68

2.86

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.68

2.86

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

455

1.53

2.86

1.4

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

691

6193

1.17

2.83

2.1

1.9

pmol/l

92.0

95.1

0.98

371

3283

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.78

2.81

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

250

2038

1.25

2.80

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

498

1.50

2.80

1.9

1.6

—

(3045142) Bone marrow Pathology biopsy report

151

1.93

2.80

1.2

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.45

2.79

1.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.45

2.79

1.3

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

180

1.84

2.78

1.1

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

166

1.88

2.76

1.7

1.6

53.4

56.3

0.13

112

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.34

2.75

6.4

4.8

umol/l

620.2

544.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.34

2.75

1.0

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.87

2.75

7.2

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.87

2.75

7.3

2.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.01

2.72

2.0

4.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.01

2.72

4.0

2.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.15

2.70

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.13

2.64

1.7

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

2.55

2.61

1.3

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

107

2.07

2.57

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

135

1.94

2.55

1.7

1.5

25.4

29.3

0.20

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.15

2.55

1.4

2.1

—

(3026480) Teichoate Ab [Titer] in Serum

7.15

2.55

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

164

1.84

2.53

2.2

2.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.51

2.53

2.6

1.6

178.1

143.4

0.63

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

150

1.88

2.51

1.9

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

152

1182

1.31

2.50

7.1

3.4

mmol/l

1.2

1.07

141

1017

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.56

2.44

1.1

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

165

1305

1.28

2.40

2.1

1.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

5.01

2.40

7.5

6.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.35

2.38

1.0

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

392

3404

1.18

2.34

1.7

1.5

nmol/l

19.4

20.2

0.47

342

2899

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

347

1.54

2.33

2.6

2.0

nmol/l

0.9

0.8

0.51

298

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.19

2.31

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

177

1.76

2.30

2.2

1.8

mg/l

25.2

21.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.13

2.28

1.0

iu/ml

10.6

5.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

231

1913

1.23

2.28

11.5

5.6

—

(21494755) Public health laboratory ask at order entry panel

141

1784

0.78

2.25

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

106

1.99

2.25

1.3

1.1

—

66.1

—

(4015189)

3.11

2.22

1.8

2.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

135

1.86

2.22

1.7

1.5

promille

1.0

1.3

0.48

108

(3024263) Appearance of Synovial fluid

2.20

2.21

1.4

1.7

—

(3033799) Differential panel - Peritoneal fluid

2.78

2.20

1.7

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.34

2.18

1.4

1.5

—

(40761511) CBC panel - Blood by Automated count

1656

17134

0.87

2.15

21.4

10.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.71

2.10

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

168

1.73

2.07

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

116

897

1.31

2.04

1.2

iu/ml

106.9

141.4

0.41

335

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

162

1.74

2.02

1.2

1.1

—

(3019225) pH of Specimen

184

1514

1.23

1.96

5.9

3.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

112

1.88

1.96

1.0

1.1

—

(21494434) Karyotype in Bone marrow

112

1.88

1.96

1.1

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

112

1.88

1.96

2.5

2.4

e6/l

406.0

799.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.45

1.93

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.12

1.92

3.0

2.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

422

1.43

1.91

1.4

ug/g

268.5

279.0

0.16

240

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.86

1.86

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.51

1.83

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

137

1.76

1.83

1.1

1.3

mmol/l

2.2

2.0

0.38

129

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

108

1.86

1.81

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

108

1.86

1.81

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

3.05

1.80

1.6

1.3

mmol/l

2.5

3.8

—

(3044290) Cell count panel - Cerebral spinal fluid

328

1.47

1.79

2.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

366

4121

0.87

1.77

1.6

mmol/l

1.6

1.4

1.25

314

3505

(40768800) Prostate Pathology biopsy report

422

0.61

1.74

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

2.2

4.8

—

(3047189) Immunofixation for 24 hour Urine

2.14

1.71

1.1

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.06

1.70

1.4

5.6

4.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.80

1.65

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.80

1.65

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.80

1.65

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1.95

1.59

4.4

3.1

mu/l

29.1

22.8

0.23

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.70

1.58

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

2.43

1.53

1.8

2.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

100

1.81

1.53

2.3

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

444

4020

1.13

1.51

4.7

3.6

estimate

0.0

0.30

143

1346

(3003888) Timothy IgE Ab [Units/volume] in Serum

258

1.48

1.50

1.2

1.1

u/ml

8.7

7.0

0.25

140

(3009214) Lutropin [Units/volume] in Serum or Plasma

487

1.34

1.49

1.3

1.5

u/l

8.7

7.4

0.36

408

(3036071) Salmonella sp Ab [Titer] in Serum

2.00

1.48

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.00

1.48

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.37

1.45

1.2

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.45

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.88

1.44

2.1

2.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.13

1.44

1.2

2.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

141

1686

0.83

1.43

1.3

1.4

—

(3014271) Vancomycin [Susceptibility]

1.97

1.43

2.6

2.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.97

1.43

1.4

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.97

1.43

1.4

2.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.31

1.43

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.31

1.43

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.31

1.43

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.31

1.43

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

561

1.31

1.42

1.3

1.4

iu/l

32.9

25.3

0.92

472

(4010399)

126

1036

1.23

1.42

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

261

2292

1.16

1.40

1.2

u/ml

9.0

12.8

0.44

925

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

193

1655

1.18

1.40

2.1

—

(4198724)

1.86

1.40

1.4

1.6

—

(36660697) Celiac disease serology panel - Serum

139

1158

1.21

1.38

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.61

1.36

1.2

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.94

1.36

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.94

1.36

1.0

2.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

575

1.30

1.35

1.1

—

0.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

370

0.64

1.34

5.7

3.1

mg/l

21.3

26.3

0.39

221

(3023410) Appearance of Cerebral spinal fluid

167

1.56

1.34

3.2

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

175

1.55

1.34

2.6

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

306

2729

1.14

1.33

3.8

3.0

mmol/l

2.4

0.16

250

2402

(3010726) Horse dander IgE Ab [Units/volume] in Serum

249

1.45

1.33

1.1

1.0

u/ml

2.0

3.6

—

(3000012) Reticulocyte production index

1.97

1.32

1.5

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

359

1.37

1.32

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

275

1.42

1.31

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.76

1.28

2.1

2.9

45.7

41.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.78

1.28

1.8

ng/l

77.2

115.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.09

1.27

2.9

3.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.94

1.27

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.00

1.27

1.4

1.1

miu/ml

1187.2

1580.7

0.80

(3035933) Granulocytes/100 leukocytes in Blood

2.29

1.26

4.6

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1672

16279

1.10

1.26

25.3

11.6

mg/l

25.0

0.02

1451

12479

(3003740) Influenza virus B Ag [Presence] in Specimen

277

1.41

1.26

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

449

1.32

1.26

1.2

1.3

miu/ml

243.3

217.7

0.14

205

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1478

14311

1.09

1.25

4.9

4.2

mu/l

2.0

2.1

0.29

1373

12981

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.40

1.24

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

350

0.65

1.23

1.1

1.4

—

(3017569) Oxygen content in Arterial blood

1.97

1.22

1.2

3.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.31

1.18

1.2

1.4

g/l

26.8

26.4

—

(3003338) MCHC [Mass/volume]

1389

14332

0.92

1.18

30.9

14.8

g/l

332.1

333.8

8.86

1376

14186

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.78

1.16

1.1

2.0

—

(3017732) Neutrophils [#/volume] in Blood

127

1071

1.20

1.15

3.6

3.1

e9/l

4.3

4.1

0.38

103

824

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.15

1.8

2.9

u/field

0.8

0.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

175

1.49

1.12

5.4

3.5

—

(4094501)

371

1.33

1.11

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.71

1.11

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1442

14836

0.92

1.10

6.2

5.4

mmol/mol

39.8

39.6

0.47

1355

13713

(3008401) Mugwort IgE Ab [Units/volume] in Serum

251

1.40

1.10

1.2

1.1

u/ml

1.5

1.6

0.05

114

(3032057) Clostridioides difficile [Presence] in Stool

2.26

1.10

1.4

2.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

363

1.33

1.10

2.4

1.4

e6/l

11.2

21.3

0.48

292

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

363

1.33

1.10

2.5

1.5

e6/l

2419.0

844.9

0.51

302

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

629

5899

1.09

4.5

3.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

1491

15315

0.92

1.09

25.9

12.6

40.1

40.5

1.15

1109

11291

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.82

1.09

2.5

4.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.19

1.08

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.93

1.06

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

138

1.53

1.02

2.1

1.2

e6/l

9335.7

72996.6

0.81

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.84

1.02

2.5

1.7

—

922607.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

403

1.30

1.02

1.1

1.0

u/ml

1.9

4.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.69

1.01

1.1

—

(44806420)

1.88

1.00

2.2

2.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

172

1.46

0.99

4.0

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

457

0.74

0.97

1.9

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

174

1.44

0.95

4.0

1.9

mmol/l

105.6

105.4

0.07

174

(3041354) Potassium [Moles/volume] in Venous blood

174

1.44

0.95

4.0

1.9

mmol/l

4.3

4.1

0.90

174

(3049717) Cytology report of Urine Cyto stain

624

1.23

0.94

2.0

2.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

260

1.35

0.93

1.8

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

175

1.43

0.92

1.1

1.0

u/ml

0.1

0.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

102

1.57

0.90

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.07

0.89

1.3

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

169

1.42

0.87

1.2

1.3

pmol/l

326.6

274.8

0.26

128

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.86

0.87

1.4

1.1

—

(3004775) Volume in Urine collected for unspecified duration

128

1.49

0.85

2.6

2.1

707.9

637.2

0.22

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

779

1.19

0.85

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.63

0.84

1.0

—

8.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

201

1806

1.12

0.84

2.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.76

0.83

1.2

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

773

1.18

0.82

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

301

2769

1.10

0.82

1.9

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

105

1.53

0.81

1.4

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

246

2245

1.11

0.79

1.8

1.5

0.63

214

2010

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

106

1.51

0.78

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.62

0.78

1.3

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

100

0.50

0.77

1.0

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

157

1.40

0.76

1.5

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

817

1.17

0.76

2.6

2.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.08

0.74

1.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

175

1.37

0.74

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

519

4908

1.07

0.74

4.0

3.2

mmol/l

7.0

8.2

7.06

453

4141

(3014133) Dog dander IgE Ab [Units/volume] in Serum

211

1.33

0.72

1.1

1.0

u/ml

4.0

4.7

0.08

(3017446) Testosterone [Moles/volume] in Serum or Plasma

155

1725

0.89

0.71

2.2

nmol/l

13.8

13.6

0.16

140

1544

(3052592) Norovirus Ag [Presence] in Stool

1.92

0.70

1.0

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.70

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

118

1.44

0.69

3.9

5.5

u/ml

99.3

50.3

—

(3000764) Benzodiazepines [Presence] in Urine

807

1.16

0.68

3.1

2.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.60

0.68

3.3

2.7

u/l

194.5

195.6

0.02

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

222

1.31

0.68

1.0

u/ml

2.5

2.2

0.10

108

(3023430) Cat dander IgE Ab [Units/volume] in Serum

196

1.33

0.67

1.1

u/ml

2.2

6.5

1.42

(1001926) Buprenorphine [Presence] in Urine by Screen method

622

1.18

0.67

3.6

2.1

—

(3027944) Amphetamines [Presence] in Urine

800

1.16

0.66

3.3

2.0

—

(3006653) Thiamine [Moles/volume] in Blood

1.54

0.65

1.2

1.3

nmol/l

139.3

139.7

0.01

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.59

0.65

1.4

1.1

—

(3019150) Specific gravity of Urine by Refractometry

359

3368

1.08

0.64

4.9

3.6

kg/l

1.0

0.63

485

(3027008) Opiates [Presence] in Urine

814

1.15

0.62

3.1

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

279

1.26

0.62

2.0

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

297

1.25

0.62

1.2

1.1

u/ml

0.7

1.9

1.30

124

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.67

0.61

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.67

0.61

1.0

1.2

—

(40768795) Lymph node Pathology biopsy report

130

1.39

0.61

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

325

1.23

0.61

3.7

2.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

262

1.26

0.61

1.2

—

(3028300) Cannabinoids [Presence] in Urine

817

1.14

0.60

3.2

2.1

—

(40761536) Microorganisms panel - Urine sediment

140

1263

1.12

0.59

4.7

3.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.50

0.59

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

131

1.38

0.59

1.2

1.5

—

(3045424) Erythrocytes [Presence] in Urine

273

1.25

0.58

1.2

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

158

1.33

0.57

4.8

3.4

57.1

56.5

0.03

102

(3016879) Cocaine [Presence] in Urine

755

1.14

0.57

3.1

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

411

1.20

0.56

5.0

4.4

—

(3048879) Bone marrow aspiration report

1.62

0.55

1.3

2.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

1.31

0.55

1.4

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1122

10952

1.05

0.52

3.7

3.0

u/l

62.0

48.6

4.17

1052

10204

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.52

0.52

1.5

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

165

1515

1.10

0.52

3.9

4.5

ug/l

8.4

23.0

1.49

133

1256

(3000330) Specific gravity of Urine by Test strip

735

1.13

0.50

5.3

3.5

—

(3005570) Glucose [Moles/volume] in Urine

136

1.33

0.49

1.6

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

1383

13580

1.05

0.49

29.3

14.4

13.8

13.6

7.94

1357

13254

(3020682) Albumin/Creatinine [Ratio] in Urine

490

4698

1.05

0.47

5.0

4.0

mg/mmol

21.7

7.8

3.72

324

3026

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.49

0.47

1.4

1.1

—

(40765096) Chromosome analysis panel by Banding

1.49

0.47

1.0

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

749

1.13

0.47

2.4

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.46

1.4

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

165

0.73

0.46

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

142

0.70

0.46

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

177

1642

1.08

0.46

1.5

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.46

1.4

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.38

0.45

1.7

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

121

1.32

0.44

1.8

1.4

—

71.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

640

1.13

0.43

1.8

—

(3003694) ABO and Rh group [Type] in Blood

451

4329

1.05

0.42

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.64

0.42

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method

529

1.14

0.41

6.5

3.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.39

0.40

5.1

7.6

—

(40768443) Skin Pathology biopsy report

606

1.13

0.40

1.1

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

278

1.19

0.40

6.7

5.0

umol/l

358.7

360.3

0.02

244

(3019550) Sodium [Moles/volume] in Serum or Plasma

1697

16776

1.04

0.39

29.1

12.8

mmol/l

139.4

139.7

4.71

1659

16261

(3021387) Prolactin [Units/volume] in Serum or Plasma

522

1.13

0.39

1.9

1.6

mu/l

335.3

285.4

0.30

480

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

382

1.15

0.38

2.8

2.2

ug/min

295.2

113.8

0.78

230

(3012516) Albumin [Mass/volume] in Urine

462

4453

1.05

0.38

4.1

3.2

mg/l

379.5

312.8

0.13

308

2865

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.27

0.36

2.0

—

(1002224) Polysomnography panel

698

1.11

0.35

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

436

4205

1.05

0.35

3.9

3.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

775

1.10

0.35

1.4

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

426

0.87

0.34

1.4

1.5

—

(4146454)

166

0.78

0.33

3.3

2.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.33

0.32

1.1

1.3

—

77.5

—

(3045414) Leukocytes [Presence] in Urine

637

1.10

0.31

2.5

1.8

—

(40768804) Tissue Pathology biopsy report

631

6149

1.04

0.31

2.3

2.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.71

0.30

1.0

1.2

—

(40768441) Liver Pathology biopsy report

111

1.26

0.30

1.1

1.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.25

0.29

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

173

0.81

0.28

2.1

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

547

1.10

0.27

5.0

3.5

u/ml

128.5

2832.7

0.86

474

(3008898) HLA-B27 [Presence]

552

0.90

0.27

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1698

16838

1.03

0.26

29.5

12.9

mmol/l

4.0

1.92

1661

16284

(3022621) pH of Urine by Test strip

925

1.07

0.26

4.0

2.8

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.23

0.25

1.0

1.3

u/l

329.7

538.9

—

(3025577) Chromium [Mass/volume] in Blood

0.72

0.24

2.2

2.0

ug/l

2.0

2.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.19

0.21

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.19

0.21

1.2

1.4

ug/l

9.3

8.9

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.0

—

(3024316) Viscosity of Plasma

0.00

0.21

0.0

1.3

—

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

104

984

1.06

0.21

1.2

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.21

0.0

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1521

15322

0.98

0.20

22.1

10.8

ml/min/173m2

81.5

83.5

2.15

1296

12342

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

683

1.07

0.20

2.0

1.8

nmol/l

38.6

38.7

0.01

662

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

197

0.86

0.19

1.2

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

291

0.89

0.19

1.5

1.4

—

(4034850)

528

0.93

0.18

16.0

7.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

257

0.89

0.17

1.3

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

162

0.86

0.16

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

184

1899

0.97

0.16

4.2

4.3

31.1

31.7

0.30

142

1236

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.10

0.15

2.6

2.3

nmol/l

150.6

153.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

162

1569

1.03

0.14

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

243

0.90

0.14

1.2

1.4

—

(4027681)

0.82

0.13

1.5

1.2

—

(44813793)

0.82

0.13

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

128

0.86

0.13

1.5

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

201

0.89

0.13

1.2

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.17

0.13

4.2

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

323

0.93

0.12

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

143

1.12

0.11

1.1

2.6

umol/l

5.5

7.8

—

102

(3047352) Trisomy 18 risk [Likelihood] in Fetus

198

0.91

0.10

1.2

1.4

—

(40768793) Breast Pathology biopsy report

268

0.93

0.09

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

655

1.04

0.09

2.8

2.1

—

(3006462) Nitrate [Presence] in Urine

1.11

0.09

2.8

3.5

—

(4281824)

126

1.11

0.09

1.4

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.79

0.08

2.8

2.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

559

1.04

0.07

1.6

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

372

1.05

0.07

2.8

2.4

u/l

4079.4

1952.0

0.27

135

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

498

0.96

0.06

2.3

1.9

pmol/l

194.6

216.2

1.38

476

(3014051) Protein [Presence] in Urine by Test strip

295

0.95

0.06

4.2

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

100

0.90

0.06

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

243

0.95

0.05

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

243

0.95

0.05

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

242

0.95

0.05

1.2

1.4

—

(3015183) Erythrocyte sedimentation rate

1.10

0.04

1.4

1.2

—

(3002256) Pathology report gross observation

200

2018

0.99

0.03

1.5

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

139

0.93

0.03

1.2

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

240

0.96

0.03

1.8

2.9

u/ml

29.7

270.5

0.74

231

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

333

3311

1.01

0.02

1.8

1.7

pmol/l

74812467.5

40362077.2

0.25

266

2765

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1034

10317

1.00

0.02

3.3

2.9

—

(4024509)

113

1.06

0.01

2.1

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

174

1.03

0.00

1.1

1.3

mmol/l

7.7

7.4

0.20

124

(3025130) Human papilloma virus identified in Specimen

135

1.04

0.00

1.6

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

330

1.00

0.00

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

185

0.97

0.00

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

185

1.03

0.00

1.5

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.1

—

(3045716) Anion gap in Serum or Plasma

0.94

0.00

1.3

1.5

mmol/l

8.8

9.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

0.97

0.00

1.0

1.8

umol/l

2.0

2.1

—

(4211845)

0.97

0.00

2.8

3.2

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

0.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

8.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.00

0.0

1.0

—

0.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.90

0.00

6.6

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.90

0.00

3.3

3.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.8

—

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

170.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_OTHILLHEART and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.38 [2.04, 2.77]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.038

During the follow-up period (1.1.1998 — 31.12.2019), 1023 out of 3349 females with I9_OTHILLHEART died.

Males

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.371 [2.05, 2.75]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.039

During the follow-up period (1.1.1998 — 31.12.2019), 1115 out of 6178 males with I9_OTHILLHEART died.

Mortality risk

Mortality risk for people of age

years, who have I9_OTHILLHEART.

N-year risk	Females	Males
1	0.213%	0.452%
5	1.362%	2.737%
10	3.343%	6.988%
15	5.763%	13.198%
20	10.061%	21.709%

Relationships between endpoints

↥

Index endpoint: I9_OTHILLHEART – Other or ill-defined heart diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other or ill-defined heart diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints